Close Menu

NEW YORK (GenomeWeb) – Fluidigm today announced the pricing of an underwritten public offering of 8,150,000 shares of its common stock at a price of $6.75 per share, for aggregate gross proceeds of about $55 million.

In addition, Fluidigm has granted underwriters of the offering a 30-day option to purchase up to 1,222,500 additional shares of common stock at the public offering price.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Guardian reports that the Mammalian Genetics Unit at the Harwell Institute is to close.

Restaurants in the US may soon serve AquaBounty's genetically modified salmon, according to the Associated Press.

Scientific research itself contributes to plastic waste and isn't very sustainable, FiveThirtyEight reports.

In Science this week: three studies from the Ruminant Genome Project, and more.